Compare FAF & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FAF | CRL |
|---|---|---|
| Founded | 1889 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 8.0B |
| IPO Year | N/A | 2000 |
| Metric | FAF | CRL |
|---|---|---|
| Price | $64.54 | $183.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 15 |
| Target Price | $76.00 | ★ $190.15 |
| AVG Volume (30 Days) | 545.1K | ★ 1.0M |
| Earning Date | 10-22-2025 | 11-05-2025 |
| Dividend Yield | ★ 3.40% | N/A |
| EPS Growth | ★ 428.61 | N/A |
| EPS | ★ 4.65 | N/A |
| Revenue | ★ $7,087,600,000.00 | $4,023,704,000.00 |
| Revenue This Year | $20.14 | N/A |
| Revenue Next Year | $7.43 | $1.66 |
| P/E Ratio | $13.91 | ★ N/A |
| Revenue Growth | ★ 20.70 | N/A |
| 52 Week Low | $53.09 | $91.86 |
| 52 Week High | $70.68 | $202.72 |
| Indicator | FAF | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 53.73 | 61.97 |
| Support Level | $61.63 | $172.95 |
| Resistance Level | $66.33 | $180.95 |
| Average True Range (ATR) | 1.20 | 5.95 |
| MACD | 0.07 | 1.75 |
| Stochastic Oscillator | 58.63 | 90.67 |
First American Financial Corp is a financial services business providing insurance through segments: Title insurance and related services segment include real estate insurance, property closing services, third-party handling of real estate funds (escrow), risk mitigation, real estate data products, and related real estate transaction services; The home warranty segment provides residential service contracts that cover residential systems, such as heating and air conditioning systems, and certain appliances against failures that occur as the result of normal usage during the coverage period; and The corporate segment includes investments in venture-stage companies, certain financing facilities and corporate services supporting the company's business operations.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.